Revenue and EBITDA grew year-over-year, supported by new hospitals and private insurance, while net profit declined due to higher costs and one-off items. Expansion continued with six new hospitals and increased capex.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.